CLVLF

Clinuvel Pharmaceuticals Limited CLVLF

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CLVLF ADIL CLVLY CMVLF CMXHF GOVXW INSM MDWD MLLCF
6M 15.44 % -48.83 % 15.86 % 240.80 % -10.62 % -89.43 % 127.07 % 12.97 % -17.06 %
YTD 9.83 % -64.77 % 8.13 % 240.80 % -20.86 % -97.81 % 130.71 % 2.61 % -14.84 %
1Y -8.90 % -60.69 % -16.82 % 67.72 % -31.56 % -97.50 % 116.15 % 8.14 % -22.22 %
3Y -23.96 % -95.33 % -27.91 % 71.77 % -26.58 % -98.28 % 643.34 % 101.42 % -41.47 %
5Y -46.15 % -99.24 % -49.88 % -81.08 % -37.76 % -99.56 % 351.41 % -27.43 % -79.59 %
10Y 309.52 % -99.63 % 303.48 % -84.02 % 103.79 % -99.59 % 820.07 % -64.68 % -84.53 %
From the beginning 290.91 % -99.63 % 20.15 % -68.21 % 4 812.31 % -99.59 % -2.19 % -84.72 % -84.53 %

Dividend

Clinuvel Pharmaceuticals Limited

Clinuvel Pharmaceuticals Limited

CSL Limited